{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,14]],"date-time":"2025-10-14T20:05:42Z","timestamp":1760472342521},"reference-count":22,"publisher":"Informa UK Limited","issue":"5","content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Future Cardiol."],"published-print":{"date-parts":[[2015,9]]},"DOI":"10.2217\/fca.15.38","type":"journal-article","created":{"date-parts":[[2015,6,19]],"date-time":"2015-06-19T13:50:12Z","timestamp":1434721812000},"page":"525-529","update-policy":"http:\/\/dx.doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":4,"title":["Reversal of Rivaroxaban Anticoagulation By Nonactivated Prothrombin Complex Concentrate in Urgent Surgery"],"prefix":"10.1080","volume":"11","author":[{"given":"Carolina","family":"Chic Acevedo","sequence":"first","affiliation":[{"name":"Hematology Service Hospital Universitario Reina Sof\u00eda\rC\u00f3rdoba\rSpain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francisco","family":"Velasco","sequence":"additional","affiliation":[{"name":"Hematology Service Hospital Universitario Reina Sof\u00eda\rC\u00f3rdoba\rSpain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Concepci\u00f3n","family":"Herrera","sequence":"additional","affiliation":[{"name":"Hematology Service Hospital Universitario Reina Sof\u00eda\rC\u00f3rdoba\rSpain"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"301","published-online":{"date-parts":[[2015,6,19]]},"reference":[{"key":"e_1_3_3_3_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa0800374"},{"key":"e_1_3_3_4_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa076016"},{"key":"e_1_3_3_5_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1007903"},{"key":"e_1_3_3_6_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1113572"},{"key":"e_1_3_3_7_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1009638"},{"key":"e_1_3_3_8_1","doi-asserted-by":"publisher","DOI":"10.1586\/erc.12.172"},{"key":"e_1_3_3_9_1","doi-asserted-by":"publisher","DOI":"10.1378\/chest.09-1584"},{"key":"e_1_3_3_10_1","doi-asserted-by":"publisher","DOI":"10.1378\/chest.10-0134"},{"key":"e_1_3_3_11_1","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehs253"},{"key":"e_1_3_3_12_1","first-page":"482","article-title":"Bleeding in patients on anticoagulant therapy: the real utility of antidotes and how to manage bleeding in patients on new-generation oral anticoagulants","volume":"25","author":"S\u00e1nchez M","year":"2013","unstructured":"S\u00e1nchez M , EscolarG, ReverterJC . Bleeding in patients on anticoagulant therapy: the real utility of antidotes and how to manage bleeding in patients on new-generation oral anticoagulants . Emergencias25, 482 \u2013 490 ( 2013 ).","journal-title":"Emergencias"},{"key":"e_1_3_3_13_1","unstructured":"European Medicines Agency (EMA) . Xarelto\u00ae \u201cSummary of Product Characteristics\u201d . Last update 15-August-2013 . www.ema.europa.eu\/docs\/en_GB\/document_library\/EPAR_-_Product_Information\/human\/000944\/WC500057108.pdf"},{"key":"e_1_3_3_14_1","volume-title":"55th American Society of Hematology (ASH) Annual Meeting and Exposition","author":"Mark C","year":"2013","unstructured":"Mark C , VandanaM, MichaelKet al. A Phase 2 Randomized, Double-Blind, Placebo-Controlled Trial Demonstrating Reversal Of Rivaroxaban-Induced Anticoagulation In Healthy Subjects By Andexanet Alfa (PRT064445), An Antidote For Fxa Inhibitors . Presented at : 55th American Society of Hematology (ASH) Annual Meeting and Exposition . New Orleans, LA, 7\u201310 December 2013 ( Abstract A3636 )."},{"key":"e_1_3_3_15_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.thromres.2014.01.017"},{"key":"e_1_3_3_16_1","doi-asserted-by":"publisher","DOI":"10.1111\/jth.12236"},{"key":"e_1_3_3_17_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.thromres.2015.01.007"},{"issue":"1","key":"e_1_3_3_18_1","first-page":"162","article-title":"Reversal of rivaroxaban anticoagulation by haemostatic agents in rats and primates","volume":"110","author":"Perzborn E","year":"2013","unstructured":"Perzborn E , GruberA, TinelHet al. Reversal of rivaroxaban anticoagulation by haemostatic agents in rats and primates . Thromb. Haemost.110 ( 1 ), 162 \u2013 172 ( 2013 ).","journal-title":"Thromb. Haemost."},{"key":"e_1_3_3_19_1","doi-asserted-by":"publisher","DOI":"10.1097\/ALN.0b013e318238c036"},{"key":"e_1_3_3_20_1","doi-asserted-by":"publisher","DOI":"10.1160\/TH12-03-0179"},{"key":"e_1_3_3_21_1","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.111.029017"},{"key":"e_1_3_3_22_1","first-page":"548272","article-title":"Managing a rivaroxaban bleed: understanding the difficulties in acute reversal of the new oral anticoagulants through a case report","volume":"2014","author":"Nannapaneni N","year":"2014","unstructured":"Nannapaneni N , SinghR, MckayP, Al-HajeiliM . Managing a rivaroxaban bleed: understanding the difficulties in acute reversal of the new oral anticoagulants through a case report . Case Rep. Hematol.2014, 548272 ( 2014 ).","journal-title":"Case Rep. Hematol."},{"key":"e_1_3_3_23_1","doi-asserted-by":"publisher","DOI":"10.1160\/TH13-05-0431"},{"key":"e_1_3_3_24_1","doi-asserted-by":"publisher","DOI":"10.1253\/circj.CJ-14-0909"}],"container-title":["Future Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.2217\/fca.15.38","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,17]],"date-time":"2024-05-17T23:36:46Z","timestamp":1715989006000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.2217\/fca.15.38"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,6,19]]},"references-count":22,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2015,9]]}},"alternative-id":["10.2217\/fca.15.38"],"URL":"https:\/\/doi.org\/10.2217\/fca.15.38","relation":{},"ISSN":["1479-6678","1744-8298"],"issn-type":[{"value":"1479-6678","type":"print"},{"value":"1744-8298","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,6,19]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ifca20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ifca20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2015-06-19","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}